NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences:
In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking to improve access and use of cancer screenings. We’re proud to be included on the list for our commitment to help increase screening rates among employees through personalized outreach.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
Massive health operation for world's largest religious gathering with 111,400 health services already delivered. 111,400…
Healthcare executive and physician brings decades of healthcare leadership, growth, and operational success to scale…
From muscle recovery and sexual health to pain relief and weight loss, men can benefit from…
Care management experts will discuss the benefits of leveraging new technologies to reduce hospital administrative…
BLOOMINGTON, Minn. and SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- CaringBridge, the nonprofit health communication platform,…
PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world…